We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World's First UHF Clinical Ultrasound Installed in Naples

By HospiMedica International staff writers
Posted on 20 Jun 2016
A world leading developer and manufacturer of Ultra High Frequency (UHF) ultrasound imaging systems has announced the installation of the first UHF clinical ultrasound system in Naples, Italy.

UHF systems have been used successfully for pre-clinical research for around 10 years, and are now for the first time being marketed for the clinical market. More...
The system has the European Conformité Européenne CE Mark of approval.

FujiFilm VisualSonics (Toronto, Canada), a subsidiary of FujiFilm SonoSite (Bothell, WA, USA) developed the Vevo MD UHF ultrasound system. The system was designed for neonatology, musculoskeletal, vascular, and dermatology imaging, and operates at frequencies up to 70 MHz, much higher than conventional ultrasound systems. The Vevo MD has a maximum image resolution of 30 microns and can be used with FujiFilm VisualSonics UHF transducers.

Dr. Roberto Grassi, professor of radiology, Second University of Naples (Naples, Italy), said, “Preclinical research is a crucial step toward establishing clinical applications, but until the launch of the Vevo MD, there were no clinically-approved ultra high frequency systems for human studies. The Vevo MD is the world’s first CE-marked, ultra high frequency ultrasound imaging system—up to 70 MHz—for clinical use, and will transform our clinical studies, enabling visualization of superficial structures in the human body. The beauty of the Vevo MD is that it is non-invasive for our patients and allows us to examine the superficial strata, visualizing structures that we could not see using conventional ultrasound. It has enabled us to determine the finer upper limb damage that occur in arthritis, allowing us to investigate the effectiveness of human drug treatments for these conditions. We are now starting to perform vascular assessment of diabetic patients, and also plan to study dermatological and systemic diseases.”

Related Links:
FujiFilm VisualSonics
FujiFilm SonoSite
Second University of Naples

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.